Search Results - "Massey, Jennifer C"
-
1
Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
Published in Frontiers in immunology (12-03-2018)“…Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system where evidence implicates an aberrant adaptive immune response in the accrual…”
Get full text
Journal Article -
2
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation
Published in Frontiers in immunology (19-01-2022)“…Autologous haematopoietic stem cell transplantation (AHSCT) is a therapeutic option for haematological malignancies, such as non-Hodgkin's lymphoma (NHL), and…”
Get full text
Journal Article -
3
Sustained immunotolerance in multiple sclerosis after stem cell transplant
Published in Annals of clinical and translational neurology (01-02-2022)“…Objective Autologous haematopoietic stem cell transplantation (AHSCT) has the potential to induce sustained periods of disease remission in multiple sclerosis…”
Get full text
Journal Article -
4
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis
Published in Journal of neurology, neurosurgery and psychiatry (01-05-2019)“…BackgroundAutologous haematopoietic stem cell transplantation (AHSCT) has been explored as a therapeutic intervention in multiple sclerosis (MS) over the last…”
Get full text
Journal Article -
5
Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis
Published in Multiple sclerosis (01-11-2021)“…Background: Given the increasing numbers of multiple sclerosis (MS) patients undergoing autologous haematopoietic stem cell transplant (AHSCT) worldwide, and…”
Get full text
Journal Article -
6
Autologous hematopoietic stem cell transplant for autoimmune diseases: evolution, evidence of efficacy, and real-world economics
Published in Blood cell therapy (10-05-2019)“…Despite an increase in the development of biological therapies for autoimmune disease (AID), a proportion of patients remain treatment refractory, resulting in…”
Get full text
Journal Article